1. Home
  2. HHS vs NSRX Comparison

HHS vs NSRX Comparison

Compare HHS & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harte-Hanks Inc.

HHS

Harte-Hanks Inc.

HOLD

Current Price

$3.70

Market Cap

34.0M

ML Signal

HOLD

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$3.45

Market Cap

37.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HHS
NSRX
Founded
1923
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.0M
37.1M
IPO Year
1994
2024

Fundamental Metrics

Financial Performance
Metric
HHS
NSRX
Price
$3.70
$3.45
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $19.67
AVG Volume (30 Days)
★ 39.2K
23.0K
Earning Date
11-09-2026
08-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 97.35
N/A
EPS
N/A
★ N/A
Revenue
★ $159,570,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.00
$1.98
52 Week High
$4.67
$9.50

Technical Indicators

Market Signals
Indicator
HHS
NSRX
Relative Strength Index (RSI) 24.92 47.13
Support Level $3.40 $2.90
Resistance Level $4.45 $3.60
Average True Range (ATR) 0.16 0.25
MACD -0.10 -0.03
Stochastic Oscillator 24.56 33.00

Price Performance

Historical Comparison
HHS
NSRX

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The company operates three business segments: Revenue Solutions; Customer Care; and Fulfillment & Logistics Services. It derives maximum revenue from Fulfillment & Logistics Services segment. The Fulfillment & Logistics Services segment includes printing, lettershop, advanced mail optimization (including commingling services), logistics and transportation optimization, monitoring and tracking, to support traditional and specialized mailings. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: